Masson Kristina

CIK 00019505011 companyWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001950501

Recent Transactions

31 trades

Purchase
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2026-01-14$1.68/sh+49,000→ 2,095,771 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-11-21$2.30/sh−19,904→ 2,046,771 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-11-14$2.24/sh−59,765→ 2,066,675 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-11-14$2.24/sh−490→ 314,706 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-08-21$1.32/sh−19,905→ 2,126,440 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-08-14$1.39/sh−490→ 315,196 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-08-14$1.39/sh−59,766→ 2,146,345 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-05-21$1.15/sh−19,904→ 2,206,111 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-05-14$1.14/sh−59,766→ 2,226,015 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-05-14$1.14/sh−491→ 315,686 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2025-03-01+390,390→ 390,390 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2025-03-01+140,540→ 140,540 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-02-21$5.54/sh−19,904→ 2,285,781 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-02-14$5.42/sh−579→ 316,177 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2025-02-14$5.42/sh−37,152→ 2,305,685 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-11-21$6.44/sh−19,910→ 2,342,837 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-11-14$7.92/sh−490→ 316,756 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-11-14$7.92/sh−59,766→ 2,362,747 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-08-21$9.19/sh−79,616→ 2,422,513 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-08-14$7.02/sh−490→ 317,246 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-05-14$8.36/sh−490→ 317,736 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2024-03-01+225,226→ 225,226 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2024-03-01+90,090→ 90,090 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2024-02-14$3.40/sh−579→ 318,226 total
Tax Payment
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2023-11-14$5.08/sh−1,900→ 318,805 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2022-11-14+80,120→ 80,120 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+26,707→ 320,705 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2022-11-14+180,269→ 180,269 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+60,090→ 2,370,097 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+503,419→ 2,310,007 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2022-11-14+934,731→ 1,806,588 total

Companies

Acrivon Therapeutics, Inc.
Director, EVP - Business Operations
$ACRV

Recent Filings

Address

C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100

WATERTOWN, MA, 02472

View on SEC.gov